article thumbnail

Moderna receives $176 million from BARDA for mRNA influenza vaccines

STAT

Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to accelerate development of messenger RNA-based pandemic influenza vaccines, the company announced in a statement Tuesday. Read the rest…

Vaccines 354
article thumbnail

Indian Immunologicals unveils pediatric dose of indigenous Hepatitis A vaccine, Havisure

Express Pharma

Hyderabad-based Indian Immunologicals (IIL) announced the launch of its pediatric dose of indigenous Hepatitis A vaccine, Havisure (0.5 IIL organised free Hepatitis A vaccination drives for children in two orphanages in Hyderabad to start with, which includes one specifically for blind children.

Vaccines 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio tech

pharmaphorum

ImmunityBio has licensed technology underpinning a COVID-19 vaccine that could be administered orally rather than by injection from UK biotech iosBio. Non-injectables remove the need for health professional-led immunisation programmes, making widespread vaccine roll-outs quicker and easier and more affordable,” Channon told pharmaphorum.

Vaccines 119
article thumbnail

Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation

pharmaphorum

Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year. In December interim phase 1/2 trial results showed the vaccine produced a lower immune response in older adults.

article thumbnail

Breaking Barriers in Women’s Health: The Role of Community Pharmacies in Supporting Women’s Health Issues

Community Pharmacy

Pharmacists offer personalized advice on common womens needs, whether understanding the dosage or side effects of medication or helping them make informed choices regarding their unique health circumstances. As womens health needs change over time, the need for screening conditions becomes more important.

article thumbnail

UK MHRA approves Pfizer-BioNTech’s bivalent Covid-19 booster

Pharmaceutical Technology

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pfizer and BioNTech’s bivalent Covid-19 booster vaccine that targets the SARS-CoV-2 virus’ original strain and the Omicron BA.4 Each booster dosage contains 15?g 1 vaccine as well as the safety results from a clinical trial underway. 5 sub-variants.

Vaccines 105
article thumbnail

Brazil grants authorisation for Sinovac’s Covid-19 vaccine in children

Pharmaceutical Technology

The Brazilian Health Regulatory Agency (Anvisa) has granted emergency use authorization for Sinovac Biotech’s Covid-19 vaccine, CoronaVac, in children aged three to five years. Subjects in this age group can receive the same vaccine dosage authorised in patients aged six to 17 years, as well as adults.